Advertisement: EBCam mid banner
Advertisement: EY Mid banner
Barr Ellison Solicitors – commercial property
Advertisement: Simpsons Creative
Advertisement: China mid banner
RealVNC mid banner careers
Mid banner advertisement: BDO
Advertisement: RSM
Advertisement: Cambridge Network
Advertisement: Kao Data Centre mid banner
ARM Innovation Hub
RealVNC mid-banner general
Advertisement: Mogrify mid banner
3 September, 2020 - 10:41 By Tony Quested

BioMedTech startups boosted by TTP-Start Codon alliance

Cambridge technology product innovator TTP has forged an exciting partnership with Start Codon, the life science and healthcare business accelerator also based in the leading UK cluster.

The alliance is designed to strengthen Start Codon’s support for life science and healthcare startups with TTP providing technical consultancy and advice, leveraging its expertise to fast-track technology development and commercialisation. 

TTP will be delivering a virtual seminar on September 17 focusing on product development and commercialisation as part of Start Codon and Cancer Research UK’s Entrepreneurial Training Scheme.

Start Codon aims to identify and recruit high-potential life science and healthcare companies from across the UK and beyond, provide seed-funding, and leverage the world-class resources of the Cambridge Cluster to reduce risk and prepare for a successful Series A fundraise. 

Under the terms of the partnership, Start Codon cohort companies will receive technology consultancy from TTP via one-to-one meetings and networking events throughout Start Codon’s six month ‘programme cycles.’ 

Both partners have committed to using their complementary networks and knowledge-base to co-host conferences and talks. Start Codon will promote TTP to its portfolio, helping the product design hothouse to connect with potential collaborators. 

Dr Michelle Griffin, clinical innovator at TTP, said: “We are delighted to be working with Start Codon to help support their talented network. This partnership allows Start Codon and its cohort companies to tap into our experience in developing products and services that deliver recurrent successful clinical, scientific and financial outcomes.”

Dr Jason Mellad, CEO of Start Codon, added: “Product development plays a critical role in the growth of new companies. Having insight from TTP – who are recognised thought-leaders and experts in the life science and healthcare space – will strengthen our programme offering from this perspective, so we can help more companies translate their innovations into the clinic.”  

• Early stage startup companies in the life sciences and healthcare space are invited to apply to the Start Codon accelerator programme via

Newsletter Subscription

Stay informed of the latest news and features